2007
DOI: 10.2217/17460751.2.1.75
|View full text |Cite
|
Sign up to set email alerts
|

Stem Cell Science in India: Emerging Economies and the Politics of Globalization

Abstract: The globalization of stem cell science is increasingly being shaped by the emerging economies of the Asia/Pacific region. Undaunted and unhampered by the more established views of the commercialization of science, countries such as India are constructing models of innovation, policies and patterns of investment that challenge such orthodoxies. This report examines the position of India within the globalization of stem cell science, its adjustments to the developing knowledge market in this field and its partic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
21
0

Year Published

2008
2008
2019
2019

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 35 publications
(21 citation statements)
references
References 17 publications
0
21
0
Order By: Relevance
“…Associated with the geographies of the bioeconomy, it is also pointed out how value-creation in the bioeconomy comprises both a material component associated with bio-resources, but nonetheless also an immaterial component in terms of knowledge and an ability to develop new knowledge [45]. Other parts of this literature revolve around issues such as the conditions for and strategies applied in building a bio-economy in various emerging economies [46][47][48][49][50][51].…”
Section: The Bio-technology Visionmentioning
confidence: 99%
“…Associated with the geographies of the bioeconomy, it is also pointed out how value-creation in the bioeconomy comprises both a material component associated with bio-resources, but nonetheless also an immaterial component in terms of knowledge and an ability to develop new knowledge [45]. Other parts of this literature revolve around issues such as the conditions for and strategies applied in building a bio-economy in various emerging economies [46][47][48][49][50][51].…”
Section: The Bio-technology Visionmentioning
confidence: 99%
“…Such framing, although it is specifically about NuTech, is inextricable from the hope and hype surrounding stem cell research, the shifting role of patients in defining trajectories of science, the redefinition of welfare services within neoliberalism, and the changing technocultural imaginaries of India (Franklin 2001, Cooper 2008, Cooper and Waldby 2014, Petersen 2009, Petersen and Seear 2011, Bharadwaj 2009, Salter et al 2007). The wife of a patient highlighted some of these tensions: "Because really, HESC (Human Embryonic Stem Cell) therapy is still considered experimental…there are relatively few patient accounts one can point to and say, 'See?!…”
Section: Discursive Contextures Euro/west-centrism and Stsmentioning
confidence: 99%
“…Moreover, it has invented a bioethical deliberative process, which is seen to be compatible with European, and North American governance norms, which gives it a well-regarded place in the global moral economy of stem cell science (Salter 2007), and helps to reassure venture capital and international biomedical firms of the social sustainability of Singaporean stem cell research. The well entrenched quality assurance ethos typical of Singapore also reassure interested parties that regulations will be uniformly implemented, in contrast to the uneven regulatory landscapes of Indian and mainland Chinese stem cell science (Salter 2007;Salter et al 2007). In 2007 and 2008 the BAC expanded its remit over stem cell regulation through two further public consultations, one about research oöcyte donation and the other about creation of cybrids 11 for SCNT research, two highly controversial areas that will require regulation if Singaporean scientists are to work at the cutting edge of stem cell science according to cosmopolitan bioethical norms.…”
Section: Stem Cell Researchmentioning
confidence: 99%